CN Stock MarketDetailed Quotes

Nanjing Hicin Pharmaceutical (300584)

Watchlist
  • 56.42
  • +1.43+2.60%
Market Closed Jan 15 15:00 CST
6.77BMarket Cap151.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nanjing Hicin Pharmaceutical (300584) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
30.80%471.53M
30.46%308.57M
36.43%142.65M
-2.60%504.36M
-4.62%360.5M
-9.56%236.53M
-10.78%104.56M
-1.64%517.83M
-0.33%377.95M
-2.25%261.55M
Operating revenue
30.80%471.53M
30.46%308.57M
36.43%142.65M
-2.60%504.36M
-4.62%360.5M
-9.56%236.53M
-10.78%104.56M
-1.64%517.83M
-0.33%377.95M
-2.25%261.55M
Other operating revenue
----
138.56%2.56M
----
21.43%2.25M
----
18.50%1.07M
----
-50.28%1.85M
----
-63.28%905.86K
Total operating cost
31.13%424.9M
30.80%268.18M
45.08%124.16M
-4.36%454.64M
-7.49%324.03M
-13.66%205.03M
-16.25%85.58M
-3.04%475.39M
-0.59%350.26M
-2.46%237.47M
Operating cost
28.67%78.37M
16.11%43.56M
6.23%19.84M
-12.02%84.98M
-11.90%60.91M
-17.06%37.52M
-10.23%18.68M
-25.71%96.59M
-25.98%69.14M
-32.13%45.23M
Operating tax surcharges
28.77%10.22M
23.23%6.61M
31.84%3.19M
-5.76%10.64M
-5.31%7.94M
-5.81%5.36M
-8.84%2.42M
15.60%11.29M
16.01%8.39M
18.83%5.69M
Operating expense
29.97%195.52M
34.56%128.61M
46.10%56.39M
-16.49%201.77M
-16.44%150.43M
-22.46%95.58M
-35.36%38.6M
-10.09%241.6M
-3.42%180.03M
-4.34%123.27M
Administration expense
64.56%104.69M
63.22%69.02M
109.87%38.66M
50.02%107.89M
13.90%63.62M
15.10%42.28M
28.85%18.42M
25.53%71.92M
21.31%55.86M
28.00%36.74M
Financial expense
-28.73%4.88M
-23.41%3.48M
-14.23%1.75M
23.57%9.09M
38.34%6.85M
44.17%4.55M
19.12%2.04M
16.55%7.36M
1.75%4.95M
-7.52%3.16M
-Interest expense (Financial expense)
-27.80%4.92M
-23.20%3.53M
-14.36%1.77M
8.59%8.98M
3.02%6.82M
20.45%4.59M
8.45%2.07M
14.06%8.27M
17.75%6.62M
-3.72%3.81M
-Interest Income (Financial expense)
47.35%-49.56K
48.92%-37.53K
52.36%-21.38K
88.18%-113.6K
88.98%-94.12K
88.84%-73.47K
78.21%-44.88K
5.38%-960.84K
-1.46%-854.06K
-7.09%-658.4K
Research and development
-8.94%31.2M
-14.37%16.9M
-20.22%4.33M
-13.63%40.28M
7.42%34.27M
-15.57%19.74M
80.20%5.43M
155.99%46.63M
121.45%31.9M
111.45%23.38M
Credit Impairment Loss
21.27%1.44M
-11.95%716.67K
597.78%1.44M
149.76%834.44K
262.64%1.19M
560.27%813.95K
-74.99%206.02K
62.95%-1.68M
113.50%327.99K
108.92%123.27K
Asset Impairment Loss
-115.03%-14.64M
-113.03%-9.35M
-26.06%-3.93M
-111.14%-9.88M
-10.02%-6.81M
4.63%-4.39M
-71.03%-3.12M
-24.10%-4.68M
-167.14%-6.19M
-144.93%-4.6M
Adjustment items of total operating cost
----
----
----
----
----
----
----
----
--0.01
---0.01
Other net revenue
-188.84%-14.76M
-174.97%-8.71M
25.39%-1.97M
-151.10%-7.91M
-41.97%-5.11M
-9.05%-3.17M
-562.07%-2.64M
47.98%-3.15M
-12.24%-3.6M
-16.52%-2.91M
Fair value change income
----
----
----
----
-97.26%1.71K
----
----
-93.08%64.18K
-93.07%62.37K
-90.37%58.52K
Invest income
-2,195.38%-2.76M
-4,273.39%-1.23M
-7,013.98%-7.47K
113.62%3.32K
---120.41K
---28.02K
---105
-2,054.13%-24.37K
----
----
Asset deal income
1,020.12%482.28K
2,014.00%482.28K
----
----
-115.26%-52.41K
-107.34%-25.2K
----
16.84%-791.83K
136.07%343.41K
138.66%343.41K
Other revenue
6.17%723.52K
44.34%664.08K
96.74%528.27K
-71.25%1.14M
-63.29%681.47K
-60.74%460.08K
-55.16%268.52K
74.70%3.96M
8.55%1.86M
4.06%1.17M
Operating profit
1.64%31.87M
11.80%31.67M
1.12%16.52M
6.40%41.81M
30.19%31.36M
33.79%28.33M
11.78%16.34M
30.53%39.29M
1.82%24.09M
-2.08%21.18M
Add:Non operating Income
14,648.23%3.58M
172.62%31.31K
12,750.32%19.3K
137.78%570.27K
-89.51%24.26K
-95.22%11.49K
-99.34%150.2
38.78%239.83K
43.35%231.26K
94.12%240.38K
Less:Non operating expense
-48.65%603.48K
-60.76%375.79K
197.62%184.97K
-26.85%1.35M
-13.39%1.18M
-14.52%957.65K
-94.04%62.15K
23.04%1.84M
34.49%1.36M
398.99%1.12M
Total profit
15.36%34.85M
14.41%31.33M
0.48%16.35M
8.86%41.03M
31.56%30.21M
34.93%27.39M
19.71%16.27M
30.97%37.69M
0.67%22.96M
-5.71%20.3M
Less:Income tax cost
26.85%2.66M
-7.44%2.45M
-52.36%1.39M
-36.86%867.34K
287.73%2.09M
222.70%2.65M
111.29%2.92M
141.03%1.37M
-82.31%539.9K
-80.11%820.83K
Net profit
14.50%32.19M
16.75%28.88M
12.02%14.96M
10.59%40.16M
25.40%28.12M
27.02%24.74M
9.37%13.36M
13.05%36.32M
13.49%22.42M
11.94%19.47M
Net profit from continuing operation
14.50%32.19M
16.75%28.88M
12.02%14.96M
10.59%40.16M
25.40%28.12M
27.02%24.74M
9.37%13.36M
13.05%36.32M
13.49%22.42M
11.94%19.47M
Less:Minority Profit
---483.87K
---279.27K
---74.09K
---54.94K
----
----
----
----
----
----
Net profit of parent company owners
16.22%32.68M
17.87%29.16M
12.57%15.04M
10.75%40.22M
25.40%28.12M
27.02%24.74M
9.37%13.36M
11.92%36.32M
11.65%22.42M
9.89%19.47M
Earning per share
Basic earning per share
16.22%0.2723
17.90%0.243
12.58%0.1253
10.74%0.3351
25.36%0.2343
26.99%0.2061
9.33%0.1113
11.91%0.3026
11.65%0.1869
9.88%0.1623
Diluted earning per share
16.22%0.2723
17.90%0.243
12.58%0.1253
10.74%0.3351
25.36%0.2343
26.99%0.2061
9.33%0.1113
11.91%0.3026
11.65%0.1869
9.88%0.1623
Other composite income
Total composite income
14.50%32.19M
16.75%28.88M
12.02%14.96M
10.59%40.16M
25.40%28.12M
27.02%24.74M
9.37%13.36M
13.05%36.32M
13.49%22.42M
11.94%19.47M
Total composite income of parent company owners
16.22%32.68M
17.87%29.16M
12.57%15.04M
10.75%40.22M
25.40%28.12M
27.02%24.74M
9.37%13.36M
11.92%36.32M
11.65%22.42M
9.89%19.47M
Total composite income of minority owners
---483.87K
---279.27K
---74.09K
---54.94K
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 30.80%471.53M30.46%308.57M36.43%142.65M-2.60%504.36M-4.62%360.5M-9.56%236.53M-10.78%104.56M-1.64%517.83M-0.33%377.95M-2.25%261.55M
Operating revenue 30.80%471.53M30.46%308.57M36.43%142.65M-2.60%504.36M-4.62%360.5M-9.56%236.53M-10.78%104.56M-1.64%517.83M-0.33%377.95M-2.25%261.55M
Other operating revenue ----138.56%2.56M----21.43%2.25M----18.50%1.07M-----50.28%1.85M-----63.28%905.86K
Total operating cost 31.13%424.9M30.80%268.18M45.08%124.16M-4.36%454.64M-7.49%324.03M-13.66%205.03M-16.25%85.58M-3.04%475.39M-0.59%350.26M-2.46%237.47M
Operating cost 28.67%78.37M16.11%43.56M6.23%19.84M-12.02%84.98M-11.90%60.91M-17.06%37.52M-10.23%18.68M-25.71%96.59M-25.98%69.14M-32.13%45.23M
Operating tax surcharges 28.77%10.22M23.23%6.61M31.84%3.19M-5.76%10.64M-5.31%7.94M-5.81%5.36M-8.84%2.42M15.60%11.29M16.01%8.39M18.83%5.69M
Operating expense 29.97%195.52M34.56%128.61M46.10%56.39M-16.49%201.77M-16.44%150.43M-22.46%95.58M-35.36%38.6M-10.09%241.6M-3.42%180.03M-4.34%123.27M
Administration expense 64.56%104.69M63.22%69.02M109.87%38.66M50.02%107.89M13.90%63.62M15.10%42.28M28.85%18.42M25.53%71.92M21.31%55.86M28.00%36.74M
Financial expense -28.73%4.88M-23.41%3.48M-14.23%1.75M23.57%9.09M38.34%6.85M44.17%4.55M19.12%2.04M16.55%7.36M1.75%4.95M-7.52%3.16M
-Interest expense (Financial expense) -27.80%4.92M-23.20%3.53M-14.36%1.77M8.59%8.98M3.02%6.82M20.45%4.59M8.45%2.07M14.06%8.27M17.75%6.62M-3.72%3.81M
-Interest Income (Financial expense) 47.35%-49.56K48.92%-37.53K52.36%-21.38K88.18%-113.6K88.98%-94.12K88.84%-73.47K78.21%-44.88K5.38%-960.84K-1.46%-854.06K-7.09%-658.4K
Research and development -8.94%31.2M-14.37%16.9M-20.22%4.33M-13.63%40.28M7.42%34.27M-15.57%19.74M80.20%5.43M155.99%46.63M121.45%31.9M111.45%23.38M
Credit Impairment Loss 21.27%1.44M-11.95%716.67K597.78%1.44M149.76%834.44K262.64%1.19M560.27%813.95K-74.99%206.02K62.95%-1.68M113.50%327.99K108.92%123.27K
Asset Impairment Loss -115.03%-14.64M-113.03%-9.35M-26.06%-3.93M-111.14%-9.88M-10.02%-6.81M4.63%-4.39M-71.03%-3.12M-24.10%-4.68M-167.14%-6.19M-144.93%-4.6M
Adjustment items of total operating cost ----------------------------------0.01---0.01
Other net revenue -188.84%-14.76M-174.97%-8.71M25.39%-1.97M-151.10%-7.91M-41.97%-5.11M-9.05%-3.17M-562.07%-2.64M47.98%-3.15M-12.24%-3.6M-16.52%-2.91M
Fair value change income -----------------97.26%1.71K---------93.08%64.18K-93.07%62.37K-90.37%58.52K
Invest income -2,195.38%-2.76M-4,273.39%-1.23M-7,013.98%-7.47K113.62%3.32K---120.41K---28.02K---105-2,054.13%-24.37K--------
Asset deal income 1,020.12%482.28K2,014.00%482.28K---------115.26%-52.41K-107.34%-25.2K----16.84%-791.83K136.07%343.41K138.66%343.41K
Other revenue 6.17%723.52K44.34%664.08K96.74%528.27K-71.25%1.14M-63.29%681.47K-60.74%460.08K-55.16%268.52K74.70%3.96M8.55%1.86M4.06%1.17M
Operating profit 1.64%31.87M11.80%31.67M1.12%16.52M6.40%41.81M30.19%31.36M33.79%28.33M11.78%16.34M30.53%39.29M1.82%24.09M-2.08%21.18M
Add:Non operating Income 14,648.23%3.58M172.62%31.31K12,750.32%19.3K137.78%570.27K-89.51%24.26K-95.22%11.49K-99.34%150.238.78%239.83K43.35%231.26K94.12%240.38K
Less:Non operating expense -48.65%603.48K-60.76%375.79K197.62%184.97K-26.85%1.35M-13.39%1.18M-14.52%957.65K-94.04%62.15K23.04%1.84M34.49%1.36M398.99%1.12M
Total profit 15.36%34.85M14.41%31.33M0.48%16.35M8.86%41.03M31.56%30.21M34.93%27.39M19.71%16.27M30.97%37.69M0.67%22.96M-5.71%20.3M
Less:Income tax cost 26.85%2.66M-7.44%2.45M-52.36%1.39M-36.86%867.34K287.73%2.09M222.70%2.65M111.29%2.92M141.03%1.37M-82.31%539.9K-80.11%820.83K
Net profit 14.50%32.19M16.75%28.88M12.02%14.96M10.59%40.16M25.40%28.12M27.02%24.74M9.37%13.36M13.05%36.32M13.49%22.42M11.94%19.47M
Net profit from continuing operation 14.50%32.19M16.75%28.88M12.02%14.96M10.59%40.16M25.40%28.12M27.02%24.74M9.37%13.36M13.05%36.32M13.49%22.42M11.94%19.47M
Less:Minority Profit ---483.87K---279.27K---74.09K---54.94K------------------------
Net profit of parent company owners 16.22%32.68M17.87%29.16M12.57%15.04M10.75%40.22M25.40%28.12M27.02%24.74M9.37%13.36M11.92%36.32M11.65%22.42M9.89%19.47M
Earning per share
Basic earning per share 16.22%0.272317.90%0.24312.58%0.125310.74%0.335125.36%0.234326.99%0.20619.33%0.111311.91%0.302611.65%0.18699.88%0.1623
Diluted earning per share 16.22%0.272317.90%0.24312.58%0.125310.74%0.335125.36%0.234326.99%0.20619.33%0.111311.91%0.302611.65%0.18699.88%0.1623
Other composite income
Total composite income 14.50%32.19M16.75%28.88M12.02%14.96M10.59%40.16M25.40%28.12M27.02%24.74M9.37%13.36M13.05%36.32M13.49%22.42M11.94%19.47M
Total composite income of parent company owners 16.22%32.68M17.87%29.16M12.57%15.04M10.75%40.22M25.40%28.12M27.02%24.74M9.37%13.36M11.92%36.32M11.65%22.42M9.89%19.47M
Total composite income of minority owners ---483.87K---279.27K---74.09K---54.94K------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianheng Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +30.13%
Sample Name
Sample Code
 +17.91%
Sample Name
Sample Code
 +15.43%
4
KUAISHOU-W
01024
+10.64%
5
JD HEALTH
06618
+9.43%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +7.31%
Sample Name
Sample Code
 +5.75%
Sample Name
Sample Code
 +3.99%
4
NVIDIA
NVDA
+3.04%
5
Tempus AI
TEM
+1.41%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -